Miriam Rábano

943 total citations
17 papers, 689 citations indexed

About

Miriam Rábano is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Miriam Rábano has authored 17 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Miriam Rábano's work include Cancer Cells and Metastasis (6 papers), Protein Kinase Regulation and GTPase Signaling (2 papers) and Sphingolipid Metabolism and Signaling (2 papers). Miriam Rábano is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Protein Kinase Regulation and GTPase Signaling (2 papers) and Sphingolipid Metabolism and Signaling (2 papers). Miriam Rábano collaborates with scholars based in Spain, United Kingdom and Canada. Miriam Rábano's co-authors include María dM Vivanco, Giacomo Domenici, Ignacio Zabalza, Robert Kypta, José Antonio López-Ruiz, Bruno M. Simões, Valentine Comaills, Oihana Iriondo, Marco Piva and J. M. Macarulla and has published in prestigious journals such as PLoS ONE, Journal of Molecular Biology and Oncogene.

In The Last Decade

Miriam Rábano

15 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miriam Rábano Spain 9 467 265 172 75 63 17 689
H. Carl Le United States 8 614 1.3× 310 1.2× 116 0.7× 65 0.9× 41 0.7× 10 824
Bita Sehat Sweden 15 855 1.8× 209 0.8× 223 1.3× 70 0.9× 55 0.9× 16 1.1k
Kah Suan Lim United States 10 538 1.2× 157 0.6× 173 1.0× 44 0.6× 42 0.7× 14 754
Jens Henrik Norum Norway 11 475 1.0× 297 1.1× 157 0.9× 48 0.6× 55 0.9× 20 731
Yuho Hayashi United States 9 469 1.0× 174 0.7× 135 0.8× 66 0.9× 38 0.6× 10 734
Steven T. Sizemore United States 17 584 1.3× 300 1.1× 186 1.1× 51 0.7× 80 1.3× 33 840
Amit D. Gujar United States 12 624 1.3× 182 0.7× 455 2.6× 60 0.8× 72 1.1× 20 971
Vishwanie Budhram‐Mahadeo United Kingdom 18 799 1.7× 255 1.0× 167 1.0× 154 2.1× 40 0.6× 45 1.1k
Matteo Rossi Italy 14 687 1.5× 323 1.2× 295 1.7× 50 0.7× 33 0.5× 19 972
Shruti Desai United States 13 476 1.0× 144 0.5× 208 1.2× 35 0.5× 39 0.6× 28 692

Countries citing papers authored by Miriam Rábano

Since Specialization
Citations

This map shows the geographic impact of Miriam Rábano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miriam Rábano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miriam Rábano more than expected).

Fields of papers citing papers by Miriam Rábano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miriam Rábano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miriam Rábano. The network helps show where Miriam Rábano may publish in the future.

Co-authorship network of co-authors of Miriam Rábano

This figure shows the co-authorship network connecting the top 25 collaborators of Miriam Rábano. A scholar is included among the top collaborators of Miriam Rábano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miriam Rábano. Miriam Rábano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Aurrekoetxea-Rodríguez, Iskander, So Young Lee, Miriam Rábano, et al.. (2024). Polyoxometalate inhibition of SOX2-mediated tamoxifen resistance in breast cancer. Cell Communication and Signaling. 22(1). 425–425. 2 indexed citations
2.
Quintana, Jon I., Sandra Delgado, Miriam Rábano, et al.. (2024). The impact of glycosylation on the structure, function, and interactions of CD14. Glycobiology. 34(3). 4 indexed citations
3.
Cusimano, Nicole, et al.. (2023). A Novel Mathematical Approach for Analysis of Integrated Cell–Patient Data Uncovers a 6-Gene Signature Linked to Endocrine Therapy Resistance. Laboratory Investigation. 104(1). 100286–100286. 1 indexed citations
4.
Stoletov, Konstantin, Irantzu Gorroño‐Etxebarria, Miriam Rábano, et al.. (2023). Intravital imaging of Wnt/β-catenin and ATF2-dependent signalling pathways during tumour cell invasion and metastasis. Journal of Cell Science. 136(3).
5.
Rábano, Miriam, et al.. (2022). Patient-Derived Explant Cultures of Normal and Tumor Human Breast Tissue. Methods in molecular biology. 2471. 301–307. 6 indexed citations
6.
Opakua, Alain Ibáñez de, Nekane Merino, Maider Villate, et al.. (2019). The Tumor Suppressor ING5 Is a Dimeric, Bivalent Recognition Molecule of the Histone H3K4me3 Mark. Journal of Molecular Biology. 431(12). 2298–2319. 22 indexed citations
7.
Domenici, Giacomo, Iskander Aurrekoetxea-Rodríguez, Bruno M. Simões, et al.. (2019). A Sox2–Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells. Oncogene. 38(17). 3151–3169. 117 indexed citations
8.
Domenici, Giacomo, Jennifer H. Steel, Miriam Rábano, et al.. (2018). Protective effect of stromal Dickkopf-3 in prostate cancer: opposing roles for TGFBI and ECM-1. Oncogene. 37(39). 5305–5324. 48 indexed citations
9.
Iriondo, Oihana, Miriam Rábano, & María dM Vivanco. (2015). FACS Sorting Mammary Stem Cells. Methods in molecular biology. 1293. 63–72. 6 indexed citations
10.
Iriondo, Oihana, Miriam Rábano, Giacomo Domenici, et al.. (2015). Distinct breast cancer stem/progenitor cell populations require either HIF1α or loss of PHD3 to expand under hypoxic conditions. Oncotarget. 6(31). 31721–31739. 43 indexed citations
11.
Domenici, Giacomo, Miriam Rábano, Marco Piva, et al.. (2014). Respuesta hormonal de las células madre de mama y resistencia a tamoxifeno. Revista de Senología y Patología Mamaria. 27(4). 149–156.
12.
Gorroño‐Etxebarria, Irantzu, et al.. (2014). Dickkopf‐3 alters the morphological response to retinoic acid during neuronal differentiation of human embryonal carcinoma cells. Developmental Neurobiology. 74(12). 1243–1254. 6 indexed citations
13.
Piva, Marco, Giacomo Domenici, Oihana Iriondo, et al.. (2013). Sox2 promotes tamoxifen resistance in breast cancer cells. EMBO Molecular Medicine. 6(1). 66–79. 271 indexed citations
14.
Gerber, Yannick N., Jean-Charles Sabourin, Miriam Rábano, María dM Vivanco, & Florence E. Perrin. (2012). Early Functional Deficit and Microglial Disturbances in a Mouse Model of Amyotrophic Lateral Sclerosis. PLoS ONE. 7(4). e36000–e36000. 57 indexed citations
15.
Brizuela, Leyre, Miriam Rábano, Patricia Gangoiti, et al.. (2007). Sphingosine-1-phosphate stimulates aldosterone secretion through a mechanism involving the PI3K/PKB and MEK/ERK 1/2 pathways. Journal of Lipid Research. 48(10). 2264–2274. 44 indexed citations
16.
Rábano, Miriam, Ana Peña, Leyre Brizuela, et al.. (2004). Angiotensin II-stimulated cortisol secretion is mediated by phospholipase D. Molecular and Cellular Endocrinology. 222(1-2). 9–20. 24 indexed citations
17.
Rábano, Miriam, Ana Peña, Leyre Brizuela, et al.. (2003). Sphingosine‐1‐phosphate stimulates cortisol secretion. FEBS Letters. 535(1-3). 101–105. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026